Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

[1]  K. Cardon,et al.  Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model. , 2012, Journal of substance abuse treatment.

[2]  R. Dworkin,et al.  Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations , 2012, PAIN®.

[3]  Robert Taylor,et al.  Dynamic risk factors in the misuse of opioid analgesics. , 2012, Journal of psychosomatic research.

[4]  B. Mccarberg,et al.  A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain , 2012, Expert opinion on pharmacotherapy.

[5]  M. Moradi-Lakeh,et al.  Sublingual buprenorphine in acute pain management: a double-blind randomized clinical trial. , 2012, Annals of emergency medicine.

[6]  C. Fox,et al.  Practices, Perceptions, and Concerns of Primary Care Physicians about Opioid Dependence Associated with the Treatment of Chronic Pain , 2012, Substance abuse.

[7]  Christopher M. Jones,et al.  CDC grand rounds , 2012 .

[8]  J. Astemborski,et al.  Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. , 2011, Addictive behaviors.

[9]  S. Ripa,et al.  Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study. , 2011, Journal of pain and symptom management.

[10]  B. Spire,et al.  Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach , 2011, Harm reduction journal.

[11]  A. Mailis-Gagnon,et al.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. , 2011, Canadian family physician Medecin de famille canadien.

[12]  A. Somogyi,et al.  Acute Pain Management in Opioid-Tolerant Patients: A Growing Challenge , 2011, Anaesthesia and intensive care.

[13]  K. Vowles,et al.  Is opioid withdrawal necessary within comprehensive pain rehabilitation programs? , 2011, PAIN.

[14]  A. Silversides.  Use of strong opioids in Canada rose sharply between 2005 and 2010 , 2011, BMJ : British Medical Journal.

[15]  R. Heimer,et al.  Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. , 2011, Drug and alcohol dependence.

[16]  W. Ling,et al.  Prescription opioid abuse, pain and addiction: clinical issues and implications. , 2011, Drug and alcohol review.

[17]  M. Kahan,et al.  Buprenorphine New treatment of opioid addiction in primary care , 2011 .

[18]  P. Shekelle,et al.  A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain. , 2011, The journal of pain : official journal of the American Pain Society.

[19]  L. Manchikanti,et al.  Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. , 2010, Pain physician.

[20]  J. Cleary,et al.  Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices. , 2010, Pain medicine.

[21]  A. Gilson.  The Concept of Addiction in Law and Regulatory Policy Related to Pain Management: A Critical Review , 2010, The Clinical journal of pain.

[22]  A. Gilson,et al.  The burden of the nonmedical use of prescription opioid analgesics. , 2009, Pain medicine.

[23]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[24]  D. Fiellin,et al.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. , 2008, Drug and alcohol dependence.

[25]  D. Vlahov,et al.  Buprenorphine use: the international experience. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  A. Dahan.  Opioid-induced respiratory effects: new data on buprenorphine , 2006, Palliative medicine.

[27]  C. Seale.  National survey of end-of-life decisions made by UK medical practitioners , 2006, Palliative medicine.

[28]  T. Christoph,et al.  Interaction of μ‐opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice , 2005, European journal of pain.

[29]  A. Muñoz,et al.  Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. , 2005, The journal of pain : official journal of the American Pain Society.

[30]  Richard Payne,et al.  Buprenorphine: considerations for pain management. , 2005, Journal of pain and symptom management.

[31]  J B Carlin,et al.  Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort. , 1999, Statistics in medicine.

[32]  W. Ling,et al.  A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. , 1996, Archives of general psychiatry.

[33]  J. Tignol,et al.  [Buprenorphine in the treatment of opiate dependence]. , 1994, Annales de medecine interne.

[34]  E. Kalso,et al.  A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. , 1993, Journal of pain and symptom management.

[35]  Ronald Melzack,et al.  The short-form McGill pain questionnaire , 1987, Pain.

[36]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[37]  D. Jasinski,et al.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. , 1978, Archives of general psychiatry.

[38]  Christopher M. Jones,et al.  CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic , 2012 .

[39]  A. Mailis-Gagnon,et al.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. , 2011, Canadian family physician Medecin de famille canadien.

[40]  S. Vosburg,et al.  The Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Patients with Chronic, Non-Malignant Pain who are Maintained on Sublingual Buprenorphine/Naloxone , 2011, Neuropsychopharmacology.

[41]  S. Abram.  A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission , 2009 .

[42]  Eorge,et al.  A COMPARISON OF LEVOMETHADYL ACETATE , BUPRENORPHINE , AND METHADONE FOR OPIOID DEPENDENCE , 2000 .

[43]  M. Gossop,et al.  The development of a Short Opiate Withdrawal Scale (SOWS). , 1990, Addictive behaviors.